Pesquisas alternativas:
elderly compared » elderly comparison (Expandir a Pesquisa), elderly care (Expandir a Pesquisa)
compared tran » compared can (Expandir a Pesquisa), compaired turlan (Expandir a Pesquisa), compared boron (Expandir a Pesquisa)
lond company » land company (Expandir a Pesquisa), lncd company (Expandir a Pesquisa), food company (Expandir a Pesquisa)
wide company » wine company (Expandir a Pesquisa), wise company (Expandir a Pesquisa), size company (Expandir a Pesquisa)
company case » company based (Expandir a Pesquisa), company a (Expandir a Pesquisa)
company can » company car (Expandir a Pesquisa), company cars (Expandir a Pesquisa), company a (Expandir a Pesquisa)
2 elderly » _ elderly (Expandir a Pesquisa), a elderly (Expandir a Pesquisa), 218 elderly (Expandir a Pesquisa)
case new » cases new (Expandir a Pesquisa), cause new (Expandir a Pesquisa), caste new (Expandir a Pesquisa)
can now » can new (Expandir a Pesquisa), can non (Expandir a Pesquisa), can ngoc (Expandir a Pesquisa)
j wide » j wilde (Expandir a Pesquisa), j wise (Expandir a Pesquisa), j wire (Expandir a Pesquisa)
ngoc » ngo (Expandir a Pesquisa)
elderly compared » elderly comparison (Expandir a Pesquisa), elderly care (Expandir a Pesquisa)
compared tran » compared can (Expandir a Pesquisa), compaired turlan (Expandir a Pesquisa), compared boron (Expandir a Pesquisa)
lond company » land company (Expandir a Pesquisa), lncd company (Expandir a Pesquisa), food company (Expandir a Pesquisa)
wide company » wine company (Expandir a Pesquisa), wise company (Expandir a Pesquisa), size company (Expandir a Pesquisa)
company case » company based (Expandir a Pesquisa), company a (Expandir a Pesquisa)
company can » company car (Expandir a Pesquisa), company cars (Expandir a Pesquisa), company a (Expandir a Pesquisa)
2 elderly » _ elderly (Expandir a Pesquisa), a elderly (Expandir a Pesquisa), 218 elderly (Expandir a Pesquisa)
case new » cases new (Expandir a Pesquisa), cause new (Expandir a Pesquisa), caste new (Expandir a Pesquisa)
can now » can new (Expandir a Pesquisa), can non (Expandir a Pesquisa), can ngoc (Expandir a Pesquisa)
j wide » j wilde (Expandir a Pesquisa), j wise (Expandir a Pesquisa), j wire (Expandir a Pesquisa)
ngoc » ngo (Expandir a Pesquisa)
1
Por Fischer, S, Weber, A, Carolus, A, Drescher, F, Götz, F, Weber, W
Publicado no J Neurointerv Surg (2017)
Assuntos:
“...New Devices...”Publicado no J Neurointerv Surg (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Cameron, Daniel J
Publicado em 2006
“... by commentators, by a case discussant in an influential medical journal, and by health insurance companies to deny...”Publicado em 2006
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Fischer, S, Weber, A, Titschert, A, Brenke, C, Kowoll, A, Weber, W
Publicado no J Neurointerv Surg (2016)
Assuntos:
“...New Devices...”Publicado no J Neurointerv Surg (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por McKay, Michael J., Rady, Kirsty, McKay, Timothy M., McKay, Jeremy N.
Publicado no Ann Transl Med (2017)
Assuntos:
“...Case Report...”Publicado no Ann Transl Med (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
“.... Instead of purchasing resources "just in case," the new paradigm may be purchasing information "just...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Lorenzo, Zaida, Burgarella, Concetta, de Heredia, Unai López, Lumaret, Roselyne, Petit, Rémy J., Soto, Álvaro, Gil, Luis
Publicado em 2009
“...BACKGROUND AND AIMS: Marginal populations of widely distributed species can be of high conservation...”Publicado em 2009
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Wang, Zhaoming, Dai, Juncheng, Hu, Nan, Miao, Xiaoping, Abnet, Christian C, Yang, Ming, Freedman, Neal D, Chen, Jinfei, Burdette, Laurie, Zhu, Xun, Chung, Charles C, Ren, Chuanli, Dawsey, Sanford M, Wang, Meilin, Ding, Ti, Du, Jiangbo, Gao, Yu-Tang, Zhong, Rong, Giffen, Carol, Pan, Wenting, Koh, Woon-Puay, Dai, Ningbing, Liao, Linda M, Yan, Caiwang, Qiao, You-Lin, Jiang, Yue, Shu, Xiao-Ou, Chen, Jiaping, Wang, Chaoyu, Ma, Hongxia, Su, Hua, Zhang, Zhendong, Wang, Lemin, Wu, Chen, Xiang, Yong-Bing, Hu, Zhibin, Yuan, Jian-Min, Xie, Lu, Zheng, Wei, Lin, Dongxin, Chanock, Stephen J, Shi, Yongyong, Goldstein, Alisa M, Jin, Guangfu, Taylor, Philip R, Shen, Hongbing
Publicado no Gut (2017)
“... conducted a meta-analysis of two published Chinese GWAS studies (2031 non-cardia gastric cancer cases...”Publicado no Gut (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Coelho, Julio C. U., Ramos, Eduardo J. B., da Costa, Marco A. R., Pissaia, Alcindo, Junior, Claudia A. P., Ivantes
Publicado em 2014
Assuntos:
“...Case Report...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
“... and challenges presented by the EU accession process and Basel II, and offer candid insight into the expanding...”
Obter o texto integral
Obter o texto integral
Livro
10
“...Continuous glucose monitoring (CGM) systems have been available for more than 15 years by now...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Morton, Katie L, Atkin, Andrew J, Corder, Kirsten, Suhrcke, Marc, Turner, David, van Sluijs, Esther M F
Publicado no BMJ Open (2017)
“... important. Following feedback along with any new information provided, participants completed round 2 4...”Publicado no BMJ Open (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
“... -- Recapitalization — New Corporate Financing Options -- From Crisis to Value Increase: How Companies Can Attain High...”
Obter o texto integral
Obter o texto integral
Livro
13
“... supported by several societies and is sponsored by several pharmaceutical companies, such as Aventis, Baxter...”
Obter o texto integral
Obter o texto integral
Livro
14
“...; Part II: Heavy metals; Part III: Modeling; Part IV: MTBE and oxygenates; Part V: Radionuclides; Part VI...”
Obter o texto integral
Obter o texto integral
Livro
15
“... trials so the optimal doses can then be selected for subsequent late phase trials. In a phase 2a clinical...”
Obter o texto integral
Obter o texto integral
Artigo
16
“... the optimal doses can then be selected for subsequent late phase trials. In a phase 2a clinical trial of new...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
“... that financial information – mostly in the form of a business case – can be a key deciding factor of whether...”
Obter o texto integral
Obter o texto integral
Artigo
18
“...Monoclonal antibodies represent one of the fastest growing areas of new drug development within...”
Obter o texto integral
Obter o texto integral
Livro
19
Por Keenan, J, Poland, F, Wilson, P, Mathie, E, Boote, J, Varley, A, Wythe, H, Wellings, A, Vicary, P, Cowe, M, Munday, D, Howe, A
Publicado no BMJ Open (2017)
“... with’ and ‘participation in’ research. Research evidence describes problems than can arise when such distinctions...”Publicado no BMJ Open (2017)
Obter o texto integral
Obter o texto integral
Artigo
20
Por Contaminated Soils Conference, Calabrese, Edward J., Kostecki, Paul T., Dragun, James.
Publicado em 2005
“... technical papers, covering a wide range of environmental issues. Volume discussion includes: Part I...”Publicado em 2005
Obter o texto integral
Livro